Here are the DEF 14A proxy statements from QT Imaging Holdings, Inc. (QTI) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow QTI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full QTI filings page.
QT Imaging Holdings is asking stockholders to vote at a virtual annual meeting on July 28, 2026 to elect two Class II directors, ratify BPM LLP as auditor for 2026, and approve an amendment to its 2024 Equity Incentive Plan. The plan amendment would increase shares of common stock reserved for equity awards from 1,827,278 by 550,900 shares (4% of currently issued and outstanding common stock) to 2,378,178. As of the June 23, 2026 record date, 13,768,903 common shares were outstanding. The proxy also highlights 2025 results: revenue rose to $18.9 million, above $18.0 million guidance and up 288% from $4.9 million in 2024, with 40 breast scanners shipped versus 12 in 2024, a 45% gross margin, operating expenses of $13.0 million versus $14.8 million, and a net loss of $21.1 million, or $2.01 per share. Net cash used in operating activities improved to $9.0 million from $10.0 million. The company raised $18.2 million in an October 2025 private placement, completed a 3:1 reverse stock split, uplisted to Nasdaq, and signed exclusive distribution agreements in Saudi Arabia and the UAE.